Skip to main content

Kerendia News

Albuminuria Reduction Accounts for Much of Finerenone Effect on CKD

MONDAY, Dec. 4, 2023 – For patients with chronic kidney disease (CKD) and type 2 diabetes, early albuminuria reduction accounts for a large proportion of the treatment effect of finerenone against...

FDA Approves Kerendia (finerenone) for the Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes

WHIPPANY, N.J.-- July 9, 2021 (BUSINESS WIRE)-- Bayer announced today the United States (U.S.) Food and Drug Administration (FDA) has approved Kerendia (finerenone), a first-in-class nonsteroidal...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Chronic Kidney Disease

Kerendia patient information at Drugs.com